• 2 million antibiotic-resistant infections leading to 23,000 deaths each year in the US - CDC

  • Superbugs resistant to all available antibiotics

  • Cutting-edge research to combat antibiotic resistance

  • Bringing scientists and clinicians together

Our Mission

Our mission is to better understand antibiotic resistance to combat this crisis and improve human health.

Learn more ยป

David S. Weiss, PhD

Featured Researcher

David S. Weiss, PhD

Our lab is focused on understanding the ways bacteria resist antibiotics as well as the host immune system during infection. We primarily study the highly antibiotic-resistant Gram-negative bacteria Acinetobacter baumannii, Klebsiella pneumoniae, and Enterobacter cloacae, aiming to identify novel therapeutics to prevent disease.

Learn More >>
James M. Hughes, MD

Featured Researcher

James M. Hughes, MD

Relationship of antimicrobial usage to resistance in human and animal populations, emerging microbial threats, foodborne diseases, healthcare-associated infections, assessment of impact of One Health interdisciplinary intervention strategies and antimicrobial drug development incentives

Learn More >>
William M. Shafer PhD

Featured Researcher

William M. Shafer PhD

My laboratory investigates the mechanisms of antibiotic resistance expressed by Neisseria gonorrhoeae with special emphasis on the role of multi-drug efflux pumps. Additional studies relate to the role of host-derived cationic antimicrobial peptides in the innate immune response to infection and how bacterial pathogens resist their action.

Learn More >>
Henry M. Blumberg, MD

Featured Researcher

Henry M. Blumberg, MD

My areas of interest in the field of antimicrobial resistance are focused on highly drug resistant tuberculosis including multidrug resistant (MDR) - and extensively drug resistant (XDR)-TB. Other areas of interest including highly drug resistant nosocomial pathogens.

Learn More >>
Eileen M. Burd, PhD, D(ABMM)

Featured Researcher

Eileen M. Burd, PhD, D(ABMM)

My primary role is to ensure up-to-date practices for antimicrobial resistance testing in the clinical microbiology laboratory based on current standards, evolving technologies, and emerging infectious diseases. I review test results with attention to unusually resistant isolates, patterns and trends, and identify organisms of interest for applied research projects.

Learn More >>
Graeme L. Conn, PhD

Featured Researcher

Graeme L. Conn, PhD

We are studying the activities and macromolecular structures of 1) ribosomal RNA methyltransferases that confer bacterial resistance to antibiotics (e.g. aminoglycosides), and 2) viral and cellular non-coding RNAs that regulate proteins of the human innate immune system.

Learn More >>
Carlos del Rio, MD

Featured Researcher

Carlos del Rio, MD

Since 1997 I have been the PI and Director of the CDC-funded Gonococcal Isolate Surveillance Project (GISP; http://www.cdc.gov/std/gisp/) Regional Laboratory in Atlanta. In that capacity I have been involved in studies of antimicrobial resistance in N. gonorrheae and have contributed data that has led to changes in the CDC guidelines for the treatment of gonorrhea.

Learn More >>
Christine M. Dunham, PhD

Featured Researcher

Christine M. Dunham, PhD

Our research is focused on understanding how gene expression is regulated during stress and from antibiotic resistance. Specifically we study the activation of toxin-antitoxin complexes that influence biofilm formation and bacterial persistence, and from ribosomal RNA modifications that confer antibiotic resistance (in collaboration with the Conn lab).

Learn More >>
Monica Farley

Featured Researcher

Monica Farley

My major laboratory research interests concern mucosal pathogenesis of Haemophilus influenzae. Experiments have focused on the mechanisms of attachment, colonization and invasion of human nasopharyngeal mucosa by H. influenzae. Current laboratory research is also focused on molecular epidemiology of invasive bacterial pathogens including H. influenzae, Streptococcus pneumoniae, and MRSA.

Learn More >>
Haian Fu, PhD

Featured Researcher

Haian Fu, PhD

We utilize chemical biology approach to discover agents that reverse microbial resistance in collaboration with microbiologists.

Learn More >>
Joanna B. Goldberg, PhD

Featured Researcher

Joanna B. Goldberg, PhD

My research program focuses on understanding mechanisms of bacterial pathogenesis, with the goal of developing novel therapies to prevent or treat life-threating infections, particular lung infections in patients with cystic fibrosis.

Learn More >>
Jesse T. Jacob, MD, MSc

Featured Researcher

Jesse T. Jacob, MD, MSc

I focus on two major, related areas of healthcare epidemiology related to multi drug resistant pathogens: 1) understanding the risk factors for, and outcomes of, infections caused these organisms, especially as it relates to antibiotic stewardship; and 2) preventing the transmission of these pathogens causing healthcare-associated infection, particularly environmental assessment and interventions.

Learn More >>
Russell Kempker, MD, MSc

Featured Researcher

Russell Kempker, MD, MSc

My research focuses on drug-resistant tuberculosis with a specific interest in the clinical impact of rapid diagnostics on treatment outcomes and the second-line anti-tuberculosis drug pharmacology.

Learn More >>
Minsu Kim, PhD

Featured Researcher

Minsu Kim, PhD

Single-cell-level study to characterize how genetically-identical bacterial cells may respond to antibiotic treatments differently

Learn More >>
Colleen S. Kraft, MD, MSc

Featured Researcher

Colleen S. Kraft, MD, MSc

Genomics for applied clinical microbiology.

Learn More >>
Bruce R. Levin, PhD

Featured Researcher

Bruce R. Levin, PhD

The goal of our research is to develop protocols for the administration of antibiotics in individual and groups of patients that will maximize the rate of clearance of infections whilst minimizing the likelihood of the emergence and ascent of resistance during therapy and the spread of resistant in the community.

Learn More >>
Karen Levy, PhD, MPH

Featured Researcher

Karen Levy, PhD, MPH

Karen Levy, PhD, MPH, Emory University, Rollins School of Public Health, Department of Environmental Health

Learn More >>
Shonna M. McBride, PhD

Featured Researcher

Shonna M. McBride, PhD

Clostridium difficile, or C. diff as it is commonly known, is considered an "Urgent" antibiotic resistance threat by the CDC. Our research is focused on two distinct aspects of C. difficile pathogenesis: the resistance of the bacterium to antimicrobials and the formation of dormant spores in the host.

Learn More >>
Nael A. McCarty, PhD

Featured Researcher

Nael A. McCarty, PhD

Basic and translational research in Cystic Fibrosis, a genetic disease characterized by recurrent pulmonary bacterial infections, often by many species resistant to antimicrobials.

Learn More >>
John E. McGowan, Jr., MD

Featured Researcher

John E. McGowan, Jr., MD

My primary research interest is the epidemiology of antibacterial resistance, especially as it applies to the healthcare setting, and as it is affected by antimicrobial use and appropriate diagnostic testing.

Learn More >>
Mark Mulligan, MD, FIDSA

Featured Researcher

Mark Mulligan, MD, FIDSA

As an infectious diseases clinician, I encounter antimicrobial resistance as a frequent challenge in my infected patients. As a translational researcher I conduct clinical and laboratory studies to discover and evaluate new drugs and diagnostic tests, as well as vaccines and monoclonal antibodies, to improve our ability to treat patients infected with resistant organisms.

Learn More >>
Polly J. Price, MA, JD

Featured Researcher

Polly J. Price, MA, JD

The recipient of a public health law grant from the Robert Wood Johnson Foundation, Professor Price has published articles on law and policy relevant to control of drug-resistant tuberculosis. She also works with the U.S.-Mexico Border Health Commission's Tuberculosis Consortium.

Learn More >>
Cassandra L. Quave, PhD

Featured Researcher

Cassandra L. Quave, PhD

The Quave research group investigates the anti-infective potential of botanical natural products for the treatment of multi-drug resistant pathogens. Research is focused on the discovery of bacterial pathogenesis and virulence inhibitors with the goal of developing adjuvant therapies to enhance and restore efficacy of existing lines of antibiotics.

Learn More >>
Philip Rather, PhD

Featured Researcher

Philip Rather, PhD

Role of RND-type efflux systems in beta-lactam resistance in Acinetobacter baumannii. Role of phase variation and quorum sensing in regulating intrinsic antibiotic resistance in A. baumannii.

Learn More >>
Timothy Read, PhD

Featured Researcher

Timothy Read, PhD

I am interested in comparative genomics of pathogens to discover novel traits that influence resistance and using genomic and metagenomic information to predict antibiotic resistance.

Learn More >>
Jyothi Rengarajan, PhD

Featured Researcher

Jyothi Rengarajan, PhD

Mechanisms of tuberculosis (TB) pathogenesis and host immunity to Mycobacterium tuberculosis (Mtb) infection in mice and humans; targeting pathogen- and host-specific factors for developing immunomodulatory therapeutics for TB and/or adjunctive therapy against drug-susceptible and drug-resistant TB.

Learn More >>
Nadine Rouphael, MD, Ms

Featured Researcher

Nadine Rouphael, MD, Ms

Clinical Trials Experience in Vaccines and Therapeutics

Learn More >>
Sarah W. Satola, PhD

Featured Researcher

Sarah W. Satola, PhD

Evaluating methods for detection of heteroresistant vancomycin intermediate Staphylococcus aureus (hVISA) and characterization of MRSA infections with reduced levels of vancomycin susceptibility.Defining the spectrum of genetic variant that cause reduced to non-susceptibility to vancomycin in S. aureus. Development of a genetic assay for vancomycin intermediate S. aureus (VISA).

Learn More >>
Raymond F. Schinazi, PhD, DSc

Featured Researcher

Raymond F. Schinazi, PhD, DSc

The Laboratory of Biochemical Pharmacology (LOBP) has a primary research focus of drug discovery and drug development of novel antiviral agents against HIV, hepatitis B and C, Chikungunya, Ebola, Dengue, and other emerging viruses. Using high-throughput screening, we determine antiviral potency, selection for drug resistance and cytotoxicity.

Learn More >>
James P. Steinberg, MD

Featured Researcher

James P. Steinberg, MD

My research interest is in the epidemiology and prevention of healthcare associated infections including those caused by antibiotic resistant pathogens. Recent work has focused on measurement and prevention of catheter associated bloodstream infections and the study of secular trends of infections caused by antibiotic resistant pathogens including MRSA.

Learn More >>
Sean Stowell, MD, PhD

Featured Researcher

Sean Stowell, MD, PhD

Our work focuses on understanding mechanism(s) whereby innate antimicrobials kill microbes.

Learn More >>
W. Robert Taylor, MD, PhD

Featured Researcher

W. Robert Taylor, MD, PhD

Infections associated with medical devices remain a significant problem in clinical medicine. Our laboratory has been specifically interested in developing novel techniques to image bacteria in vivo and to apply these strategies for targeted delivery of antibiotics.

Learn More >>
Jorge E. Vidal, PhD

Featured Researcher

Jorge E. Vidal, PhD

My laboratory investigates (1) antibiotic resistance mechanism(s) of S. pneumoniae strains, including gene transfer mechanisms, (2) global epidemiology of pneumococcal strains resistant to antibiotics, (3) the pressure of current pneumococcal vaccines on the spread of, or changes on, antibiotic resistance and (4) role of pneumococcal biofilm structures on antimicrobial resistance.

Learn More >>

Upcoming Event

Radical Approaches to Antibiotics and Antibiotic Resistance
James J. Collins, MD
Termeer Professor of Medical Engineering & Science Professor, Department of Biological Engineering, Massachusetts Institute of Technology
Broad Institute of MIT and Harvard Wyss Institute for Biologically Inspired Engineering, Harvard University
Date: Thursday, August 18, 2016
Time: 4 p.m.
Location: Emory Health Sciences Research Building 

More Seminars »

Support the Antibiotic Resistance Center

Support the Emory Antibiotic Resistance Center and let us together combat this crisis and preserve the power of antibiotics for generations to come.

Learn More »